Launch of Biomedical Genomics Workbench

Author:

QIAGEN Digital Insights

Launch of Biomedical Genomics Workbench

Biomedical Genomics Workbench enables you to find the signal in noise in your cancer and hereditary disease NGS data with ease and unsurpassed accuracy

[video src=”https://clcbio.23video.com/v.ihtml/player.html?token=43515f6541106cf4bbd6cc03859f5ff0&source=embed&photo%5fid=11478351″]

 

Biomedical Genomics Workbench provides a complete solution for NGS data analysis for biomarker discovery.  It is fast, intuitive, and easy to use, and at the same time, it’s flexible and customizable. It enables you to get accurate and trustworthy results from whole genome, exome, targeted amplicon, transcriptome as well as epigenetic NGS data in one step. You can spend only half the time compared to open source solutions, while realizing greater than 95% sensitivity for the detection of germline and low frequency variants, including CNV with high specificity.

In addition Biomedical Genomics Workbench provides specific functionalities for cancer, hereditary, and rare diseases data analysis and advanced visualization for validation of results:

  • Low frequency variant detection in mosaic diseases and heterogeneous cancer samples
  • Test for known actionable variants without doing variant calling
  • Copy Number Detection
  • Probabilistic variant detection for hereditary diseases
  • Specific functionalities for targeted amplicon sequencing analysis
  • Identification of somatic variants from tumor/normal paired samples
  • Filtering and annotating with dbSNP, ClinVar, COSMIC, and other databases

And of course, Biomedical Genomics Workbench is part of QIAGEN’s sample-to-insight workflow:

  • Get the best solution for data analysis and data interpretation in one streamlined solution by combining it with Ingenuity® Variant Analysis and Ingenuity® Pathway Analysis
  • Analyze QIAGEN GeneRead DNASeq Amplicon Panel data in one step
  • Use Biobase Genome Trax directly within the software
  • Combine with Transfac® to identify and annotate transcription factor binding sites

Sign up for a trial!